Syngene International, the contract research and manufacturing services arm of Biocon, reported 19% year-on-year (YoY) drop in net profit to Rs.76 crore in Q1FY25 led by discovery services revenue taking a hit due to funding constraints at US biotechs.
| Subscribe To Our Free Newsletter |
